Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

320
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
320
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

277
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
277
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

464
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
464
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

262
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
262
Pneumothorax-II01:27

Pneumothorax-II

852
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
852
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

C-reactive protein binds to integrin α2 and Fcγ receptor I, leading to breast cell adhesion and breast cancer progression.

Oncogene·2017
Same author

Reduced tissue osmolarity increases TRPV4 expression and pro-inflammatory cytokines in intervertebral disc cells.

European cells & materials·2016
Same author

BAX inhibitor-1 enhances cancer metastasis by altering glucose metabolism and activating the sodium-hydrogen exchanger: the alteration of mitochondrial function.

Oncogene·2016
Same author

Renal Cell Cancer in a European Regional Renal Transplant Population: Is There a Role for Immediate Native Renal Radiological Surveillance Before and After Transplantation?

Transplantation proceedings·2015
Same author

Tuberculosis in umbilical cord blood transplant recipients: clinical characteristics and challenges.

Bone marrow transplantation·2015
Same author

Gα12 gep oncogene deregulation of p53-responsive microRNAs promotes epithelial-mesenchymal transition of hepatocellular carcinoma.

Oncogene·2014

Related Experiment Video

Updated: Jan 9, 2026

Pulmonary Embolism III: Nursing Management
01:27

Pulmonary Embolism III: Nursing Management

Published on: June 19, 2025

320

Complementation analysis of fatty acid oxidation disorders.

A Moon, W J Rhead

    The Journal of Clinical Investigation
    |January 1, 1987
    PubMed
    Summary
    This summary is machine-generated.

    Fatty acid oxidation disorders were studied using fibroblast cell lines. Complementation analysis revealed two distinct genetic defects in severe multiple acyl-CoA dehydrogenation disorder, pinpointing electron transfer flavoprotein or its reductase.

    More Related Videos

    Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
    01:29

    Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

    Published on: June 19, 2025

    277
    Pulmonary Embolism I: Introduction
    01:29

    Pulmonary Embolism I: Introduction

    Published on: June 19, 2025

    464

    Related Experiment Videos

    Last Updated: Jan 9, 2026

    Pulmonary Embolism III: Nursing Management
    01:27

    Pulmonary Embolism III: Nursing Management

    Published on: June 19, 2025

    320
    Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
    01:29

    Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

    Published on: June 19, 2025

    277
    Pulmonary Embolism I: Introduction
    01:29

    Pulmonary Embolism I: Introduction

    Published on: June 19, 2025

    464

    Area of Science:

    • Biochemistry
    • Genetics
    • Cell Biology

    Background:

    • Fatty acid oxidation disorders (FAODs) are inherited metabolic diseases.
    • Defects in acyl-CoA dehydrogenase enzymes impair fatty acid metabolism.
    • Accurate diagnosis and genetic characterization are crucial for patient management.

    Purpose of the Study:

    • To investigate the functional consequences of various FAODs using fibroblast cell models.
    • To identify the specific genetic defects underlying multiple acyl-CoA dehydrogenation disorder (MADD).
    • To establish complementation groups within MADD for improved diagnostic classification.

    Main Methods:

    • Assay of [9,10(n)-3H]palmitate oxidation in patient-derived fibroblast monolayers.
    • Polyethylene glycol (PEG) mediated cell fusion to assess complementation between different FAOD cell lines.
    • Analysis of complementation groups in severe MADD to identify affected genes.

    Main Results:

    • Fibroblast activity varied significantly across different FAODs, with severe MADD showing the lowest residual activity (7%).
    • Complementation was observed between MADD, medium-chain acyl-CoA dehydrogenase (MCAD) deficiency, and long-chain acyl-CoA dehydrogenase (LCAD) deficiency cell lines.
    • Two complementation groups were identified in severe MADD, corresponding to electron transfer flavoprotein (ETF) and ETF:ubiquinone oxidoreductase (ETFQOR) deficiencies.
    • ETFQOR deficiency presented a more severe metabolic block than ETF deficiency.

    Conclusions:

    • Cell fusion complementation is a valuable tool for dissecting genetic defects in FAODs.
    • Severe MADD can be attributed to defects in either ETF or ETFQOR.
    • Two patients with previously unreported severe MADD were assigned to the ETFQOR-deficient group, refining diagnostic understanding.